[ Price : $8.95]
Federal Register notice: FDA revokes the Emergency Use Authorizations issued to LifeHope Labs for the LifeHope 2019-nCoV Real-Time...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Current Good Manufacturing Practice and Preventive Controls...[ Price : $8.95]
FDA sends AstraZeneca a complete response letter on its supplemental BLA for Fasenra (benralizumab) for patients with inadequately...[ Price : $8.95]
Federal Register notice: FDA determines that GE Healthcares MPI DMSA kidney reagent (Technetium Tc-99m Succimer Kit), Injectable, ...[ Price : $8.95]
FDA classifies as Class 1 a Baxter Healthcare recall of its Sigma Spectrum Infusion Pumps with Master Drug Library (Version 8) and...[ Price : $8.95]
FDA extends by three months its review of Incytes supplemental NDA for Opzelura (ruxolitinib) cream for treating vitiligo.[ Price : $8.95]
FDA warns against using Apyx Medicals Renuvion/J-Plasma device for certain aesthetic procedures, such as those intended to improve...[ Price : $8.95]
FDA approves AstraZenecas Lynparza (olaparib) for the adjuvant treatment of adult patients with deleterious or suspected deleterio...